US SB3781 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on May 20 2020 - 25% progression, died in committee
Action: 2020-05-20 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 20 2020 - 25% progression, died in committee
Action: 2020-05-20 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to increase reporting of, help mitigate potential shortages related to, and promote, accountability and transparency for pharmaceuticals and medical devices.
Title
PART Act Pharmaceutical Accountability, Responsibility, and Transparency Act
Sponsors
Sen. Gary Peters [D-MI] |
History
Date | Chamber | Action |
---|---|---|
2020-05-20 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
Business records
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Government information and archives
Health
Health technology, devices, supplies
Manufacturing
Prescription drugs
Public contracts and procurement
Strategic materials and reserves
Trade restrictions
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Government information and archives
Health
Health technology, devices, supplies
Manufacturing
Prescription drugs
Public contracts and procurement
Strategic materials and reserves
Trade restrictions
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/3781/all-info |
Text | https://www.congress.gov/116/bills/s3781/BILLS-116s3781is.pdf |